FindA University Ltd Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
FindA University Ltd Featured PhD Programmes
University College London Featured PhD Programmes
University of Southampton Featured PhD Programmes
"knowledge"×
10 miles

Pharmacology / Toxicology (knowledge) PhD Projects, Programs & Scholarships

We have 21 Pharmacology / Toxicology (knowledge) PhD Projects, Programs & Scholarships

  • "knowledge" ×
  • Pharmacology / Toxicology×
  • clear all
Order by 
Showing 1 to 10 of 21
  Defining the role of p53 in cancer immunotherapy
  Prof Y. Haupt, Dr S. Haupt, Dr P. Neeson
Applications accepted all year round

Funding Type

PhD Type

Despite clear evidence of an association between the tumour suppressor p53 and immunity, a gap in knowledge exists regarding its role in modulating immune responses, or its value in predicting patient responses to immunotherapy.
  Ensuring chemical safety through toxicity studies in Daphnia using state-of-the-art molecular, imaging and modelling approaches
  Prof M Viant, Dr B Campos, Dr C Rivetti, Dr I Sorrell
Application Deadline: 5 July 2019

Funding Type

PhD Type

This exciting 4-year BBSRC iCASE PhD opportunity bridges the University of Birmingham’s (*) metabolomics team and Unilever’s Safety and Environmental Assurance Centre (SEAC), both having state-of-the-art facilities and renowned research programmes, thereby creating an excellent environment for this challenging yet impactful research project.
  EPSRC Centre for Doctoral Training in Sustainable Approaches to Biomedical Science: Responsible and Reproducible Research - SABS

Funding Type

PhD Type

Good degree in the Physical or Life Sciences? Interested in biological or medical research? We offer fully-funded PhD places across the Oxford Doctoral Training Centre programmes.
  Modelling the cardiovascular side-effects of anaesthesia
  Prof I Bojak
Applications accepted all year round

Funding Type

PhD Type

"Propofol is currently the anaesthetic most commonly employed in surgical operations. However, it has a variety of cardiovascular side-effects that are potentially life-threatening, in particular for fragile patients.
  Combining melatonin and omega-3 fatty acids to manage chemotherapy-induced peripheral neuropathy and spinal injury-induced neuropathic pain.
  Prof H Galley, Dr W Huang
Application Deadline: 28 June 2019

Funding Type

PhD Type

Chemotherapy-induced peripheral neuropathy (CIPN) is a common and debilitating complication during cancer treatment, which can lead to chemotherapy drug dose reduction or treatment cessation.
  Synthesis of Microcarriers for Focal Drug Delivery to the Brain
  Dr B Newland
Applications accepted all year round

Funding Type

PhD Type

For neurodegenerative diseases, where a specific cell type is lost, it is possible to consider replacing these cells to restore the lost function.
  PhD studentship opportunities in Environment and Health

Funding Type

PhD Type

 We are pleased to invite applications for 3-year PhD studentships at the MRC Centre for Environment and Health. Studentships will be based at the Department of Epidemiology and Biostatistics (Imperial College London), and/or at the Environmental Research Group (King's College London).
  PhD studentship opportunities in Environment and Health

Funding Type

PhD Type

 We are pleased to invite applications for 3-year PhD studentships at the MRC Centre for Environment and Health. Studentships will be based at the Department of Epidemiology and Biostatistics (Imperial College London), and/or at the Environmental Research Group (King's College London).
  The role of isothiocyanates-derived from natural sources in uveal melanoma chemoprevention (ref: SF18/APP/McDermott)
  Prof A McDermott, Prof M Panagiotidis, Dr G Koutsidis
Applications accepted all year round

Funding Type

PhD Type

Uveal melanoma is the most frequent primary intraocular tumor, in Caucasian adults, and one that is very difficult to treat once it becomes metastatic.
  Development of targeted therapy for acute myeloid leukaemia with mutations in isocitrate dehysdrogenase
  Dr L. Kats
Applications accepted all year round

Funding Type

PhD Type

Acute Myeloid Leukaemia (AML) is an aggressive disease with poor prognosis and development of novel treatment options is urgently needed.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.